2008
DOI: 10.1155/2008/679137
|View full text |Cite
|
Sign up to set email alerts
|

Peroxisome Proliferators‐Activated Receptor (PPAR) Modulators and Metabolic Disorders

Abstract: Overweight and obesity lead to an increased risk for metabolic disorders such as impaired glucose regulation/insulin resistance, dyslipidemia, and hypertension. Several molecular drug targets with potential to prevent or treat metabolic disorders have been revealed. Interestingly, the activation of peroxisome proliferator-activated receptor (PPAR), which belongs to the nuclear receptor superfamily, has many beneficial clinical effects. PPAR directly modulates gene expression by binding to a specific ligand. Al… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
66
0

Year Published

2009
2009
2021
2021

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 74 publications
(66 citation statements)
references
References 121 publications
0
66
0
Order By: Relevance
“…PPAR ␥ is expressed at high levels in adipose tissue [9] , where it plays an important role in the regulation of genes involved in adipocyte differentiation, lipid storage, glucose metabolism, and insulin sensitivity [30,31] . Differentiated adipocytes are required for expression of proteins involved in hormonal action and signaling, lipogenesis and lipolysis, fatty acid binding, and insulinsensitive glucose transport [4,32] .…”
Section: Discussionmentioning
confidence: 99%
“…PPAR ␥ is expressed at high levels in adipose tissue [9] , where it plays an important role in the regulation of genes involved in adipocyte differentiation, lipid storage, glucose metabolism, and insulin sensitivity [30,31] . Differentiated adipocytes are required for expression of proteins involved in hormonal action and signaling, lipogenesis and lipolysis, fatty acid binding, and insulinsensitive glucose transport [4,32] .…”
Section: Discussionmentioning
confidence: 99%
“…PPARg2, selectively expressed in adipocytes, induces the expression of genes (for example, aP2) necessary for the generation and maintenance of the adipogenic phenotype as well as glucose and lipid metabolism. 25,26) Since PPARg2 exerts the effects on insulin sensitivity and glucose homeostasis, 27) and it is required for adipocyte differentiation, 28) the increase in its expression may manage the level of blood glucose by increasing glucose uptake into mature adipocytes. In a previous study, sakuranetin was revealed to significantly induce adipogenesis, increase insulin-stimulated glucose uptake and improve PPARg mRNA expression, but fail to exhibit PPARg ligand activity even at high doses (100 mM) in luciferase reporter assay.…”
Section: Discussionmentioning
confidence: 99%
“…3b) (Cho et al, 2008;Musri et al, 2007). The addition of troglitazone induces the exchange of suppressive NCoR/SMRT complexes through causing the expression of PPARγ coactivator 1α (PGC-1α) (Guan et al, 2005).…”
Section: Regulation Of Pparγ By Ligandsmentioning
confidence: 99%